Revenue
2022
2023
2024
2025
Viromed Medical (VME)
Price€6.00Cached quote
Net income
2022
2023
2024
2025
Free cash flow
No reported data
Total cash / debt
CashTotal debt
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | €5.1M | €1.1M | €0 | €0 |
| Operating expenses | €3.1M | €3.2M | €358,958.23 | €160,474.1 |
| Operating income | −€862,273.32 | −€3.5M | −€358,958.23 | −€160,474.1 |
| Operating margin | −16.95% | −311.01% | — | — |
| EBITDA | −€9,707.08 | −€3.1M | −€108,958.23 | −€160,474.1 |
| EBITDA margin | −0.19% | −279.05% | — | — |
| Net income | €604,514.36 | −€3.1M | −€110,411.67 | −€160,617.3 |
| Net profit margin | 11.88% | −274.95% | — | — |
| Basic EPSper basic share | €0.03 | -€0.15 | -€0.01 | -€0.01 |
| Diluted EPSper diluted share | €0.03 | -€0.15 | -€0.01 | -€0.01 |